JULIANNE VESCIGLIO: Open Payments
NPI 1295355360 · BRIDEGPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,265 in 84 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $32 · 2025 $2,265
Food & beverage: $2,265
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $525 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $431 |
| ABBVIE INC. | 17 | $407 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $130 |
| Corium, LLC | 5 | $122 |
| Teva Pharmaceuticals USA, Inc. | 5 | $121 |
| Neurocrine BioSciences, Inc. | 5 | $107 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Supernus Pharmaceuticals, Inc. | 3 | $74 |
| Tris Pharma Inc | 4 | $67 |
Products named: SPRAVATO, CAPLYTA, VRAYLAR, TRINTELLIX, Azstarys, INGREZZA, AUSTEDO XR, REXULTI.
Industry payments across CT — which companies pay providers there.
